164 Long-term (four year) 28-joint count disease activity score (C-reactive protein) remission and improvements in skin disease with apremilast: phase III results from PALACE3 | Zendy

AI Assistant Blog Pricing

164 Long-term (four year) 28-joint count disease activity score (C-reactive protein) remission and improvements in skin disease with apremilast: phase III results from PALACE3

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.